8 research outputs found
Participants’ perspectives on mindfulnessbased cognitive therapy for inflammatory bowel disease: a qualitative study nested within a pilot randomised controlled trial
Background: Mindfulness-based interventions have shown to improve depression and anxiety symptoms as well as
quality of life in patients with inflammatory bowel disease (IBD). However, little is known about the experiences of
this group of patients participating in mindfulness interventions. This paper sets out to explore the perspectives of
patients with IBD recruited to a pilot randomised controlled trial (RCT) of mindfulness-based cognitive therapy
(MBCT) about the intervention.
Methods: In a qualitative study nested within a parallel two-arm pilot RCT of mindfulness-based cognitive therapy
for patients with IBD, two focus group interviews (using the same schedule) and a free text postal survey were
conducted. Data from both were analysed using thematic analysis. Data and investigator triangulation was
performed to enhance confidence in the ensuing findings.
Forty-four patients with IBD were recruited to the pilot RCT from gastroenterology outpatient clinics from two
Scottish NHS boards. Eighteen of these patients (ten from mindfulness intervention and eight from control group)
also completed a postal survey and participated in two focus groups after completing post intervention
assessments.
Results: The major themes that emerged from the data were the following: perceived benefits of MBCT for IBD,
barriers to attending MBCT and expectations about MBCT. Participants identified MBCT as a therapeutic, educational
and an inclusive process as key benefits of the intervention. Key barriers included time and travel constraints.
Conclusions: This qualitative study has demonstrated the acceptability of MBCT in a group of patients with IBD.
Participants saw MBCT as a therapeutic and educational initiative that transformed their relationship with the illness.
The inclusive process and shared experience of MBCT alleviated the sense of social isolation commonly associated
with IBD. However, time commitment and travel were recognised as a barrier to MBCT which could potentially
influence the degree of therapeutic gain from MBCT for some participants.
Keywords: Inflammatory bowel disease, Mindfulness, MBCT, Focus groups, Qualitative stud
Allergic sensitization: screening methods
Experimental in silico, in vitro, and rodent models for screening and predicting protein sensitizing potential are discussed, including whether there is evidence of new sensitizations and allergies since the introduction of genetically modified crops in 1996, the importance of linear versus conformational epitopes, and protein families that become allergens. Some common challenges for predicting protein sensitization are addressed: (a) exposure routes; (b) frequency and dose of exposure; (c) dose-response relationships; (d) role of digestion, food processing, and the food matrix; (e) role of infection; (f) role of the gut microbiota; (g) influence of the structure and physicochemical properties of the protein; and (h) the genetic background and physiology of consumers. The consensus view is that sensitization screening models are not yet validated to definitively predict the de novo sensitizing potential of a novel protein. However, they would be extremely useful in the discovery and research phases of understanding the mechanisms of food allergy development, and may prove fruitful to provide information regarding potential allergenicity risk assessment of future products on a case by case basis. These data and findings were presented at a 2012 international symposium in Prague organized by the Protein Allergenicity Technical Committee of the International Life Sciences Institute’s Health and Environmental Sciences Institute